RecallRadar

FDA Drug recall D-0259-2026

Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Dist…

On 2026-01-21 the FDA classified a Class II recall of Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Dist… by Alvogen, citing product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0259-2026
ClassificationClass II
Statusongoing
Initiated2025-12-31
Published2026-01-21
Last updated2026-09-13 11:52 UTC
CompanyAlvogen
DistributionUS

Product

Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.

Reason

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Identifiers

ndc47781-640-90
ndc47781-640-10
ndc47781-643-90
ndc47781-643-10
ndc47781-646-90
ndc47781-646-10
ndc47781-649-90
ndc47781-649-10
ndc47781-651-90
ndc47781-651-10
ndc47781-654-90
ndc47781-654-10
ndc47781-657-90
ndc47781-657-10
ndc47781-659-90
ndc47781-659-10
ndc47781-662-90
ndc47781-662-10
ndc47781-665-90
ndc47781-665-10
ndc47781-668-90
ndc47781-668-10
ndc47781-671-90
ndc47781-671-10
ndc47781-728-90
ndc47781-721-90
code_infoLot # MHA21825, Exp Date: December 31, 2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0259-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.